Add BrightSurf on Google Email

Predicting the future in ovarian cancer

Researchers identified kisspeptin and GPR54 as independent prognostic biomarkers specific for ovarian clear cell carcinoma. These molecular markers are associated with a favourable prognosis and could potentially be used to monitor disease activity or as therapeutic agents in women with this subtype of ovarian cancer.

SourceBMC (BioMed Central)·JournalBMC Medicine·DateNov 14, 2007

Other highlights in the July 7 JNCI

A new study found that most phase I studies of targeted, non-cytotoxic anticancer agents used traditional toxicity endpoints to determine the recommended dose, while non-traditional endpoints were rarely incorporated. Researchers also identified a potential mechanism for acrylamide's mutagenicity and discovered genetic polymorphisms as...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 6, 2004

Herpes simplex virus-2 may increase risk of cervical cancer

A study found that herpes simplex virus-2 (HSV-2) infection may increase the risk of invasive cervical cancer, particularly when combined with human papillomavirus (HPV) infection. The study analyzed data from seven countries and detected HSV-2 antibodies in nearly half of women with cervical cancer, but not in most women without the d...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 5, 2002